Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuropace Inc
(NQ:
NPCE
)
13.30
-0.17 (-1.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuropace Inc
< Previous
1
2
3
4
Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via
Benzinga
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace's Return On Capital Employed Overview
May 18, 2023
Via
Benzinga
Recap: NeuroPace Q1 Earnings
May 04, 2023
Via
Benzinga
Looking Into NeuroPace's Return On Capital Employed
March 08, 2023
Via
Benzinga
NeuroPace Earnings Preview
March 01, 2023
Via
Benzinga
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces CEO Transition
June 28, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
People Are Lining Up For Elon Musk's Neuralink Brain Implant — Here's How You Can Invest In Brain Technology Startups
June 14, 2023
Via
Benzinga
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 24, 2023
To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace’s RNS System
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Dow Jumps Over 300 Points; S&P 500 Rises 1.5%
March 03, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P...
Via
Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 03, 2023
Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via
Benzinga
Nasdaq Up 150 Points; Crude Oil Rises 1%
March 03, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P...
Via
Benzinga
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
March 02, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via
Benzinga
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 13, 2023
Via
Benzinga
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
January 09, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 02, 2023
Via
Benzinga
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 30, 2022
From
NeuroPace, Inc.
Via
Business Wire
$10 Million Bet On Canoo? Check Out These 3 Stocks Under $3 Insiders Are Buying
November 25, 2022
The Nasdaq Composite closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.